Recombinant DNA Technology Market Report by Product (Medical, Non-Medical), Component (Expression System, Cloning Vector), Application (Food and Agriculture, Health and Disease, Environment, and Others), End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, and Others), and Region 2024-2032
The global recombinant DNA technology market size reached US$ 764.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,119.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The ongoing advancements in genetic engineering and biotechnology, the growing demand for biopharmaceuticals, increasing shift towards personalized medicines, and the rising prevalence of chronic diseases are primarily driving the market's growth.
Read More: https://www.imarcgroup.com...
The global recombinant DNA technology market size reached US$ 764.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,119.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The ongoing advancements in genetic engineering and biotechnology, the growing demand for biopharmaceuticals, increasing shift towards personalized medicines, and the rising prevalence of chronic diseases are primarily driving the market's growth.
Read More: https://www.imarcgroup.com...
Recombinant DNA Technology Market Size & Report [2032]
The global recombinant DNA technology market reached a value of US$ 764.8 Billion in 2023 and grow at a CAGR of 4.1% to reach US$ 1,119.0 Billion by 2032.
https://www.imarcgroup.com/recombinant-dna-technology-market
3 months ago